Baker Hughes Incorporated (BHI), Anadarko Petroleum Corporation (APC), Teva Pharmaceutical Industries Ltd (ADR) (TEVA): Top 3 Stock Investments of Millennium Management

Baker_Hughes_Logo

Millennium Management is among one of the most popular investment firms with investment career of over 25 years and as on October 31, 2014 the firm had over $24.1 billion worth of assets under management. The recent SEC 13F filing of Millennium Management on November 14 highlights its primary stock investments including Baker Hughes Incorporated (NYSE:BHI), Anadarko Petroleum Corporation (NYSE:APC), Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA).

Baker Hughes Incorporated (NYSE:BHI) is the primary stock investment of Millennium Management with 6,155,711 shares of the company at market value of $400 million. The directors of Baker Hughes Incorporated (NYSE:BHI) have agreed for a $35 billion takeover bid from Halliburton Company (NYSE:HAL). These two companies with combined assets and market share are likely to dominate petroleum service industry along with Schlumberger Limited. (NYSE:SLB). The shares of Baker Hughes Incorporated (NYSE:BHI) closed at $63.99 in the extended hour trading on November 18, 2014.

Baker_Hughes_Logo

Anadarko Petroleum Corporation (NYSE:APC) is the second largest stock investment of Millennium Management with investments worth $335 million and 3,310,058 shares of the company. Anadarko Petroleum Corporation (NYSE:APC) announced its third quarter 2014 financial results with net income of $2.12 (diluted) per share. Some of the primary investors of Anadarko Petroleum Corporation (NYSE:APC) include Mason Capital Management, Soroban Capital Partners, and Elliott Management.

The third largest stock holding of Millennium Management include Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) with 5,206,942 shares of the company at current market value of $279 million. Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) announced its third quarter 2014 financial results with revenues of $5.1 billion and earnings per share of $1.02. The pharmaceutical company reported growth of over 200% in its net cash flow from operations at $1.4 billion. Some of the primary investors of the company include Point State Capital, Soros Fund Management, and Highfields Capital Management.

This article has been written by Prakash Pandey.

Richest Cities In the World

Top 10 Best Selling Apps ForIphone

Related posts

*

*

Top

Warren Buffett's Best Picks

Warren Buffett's these stock picks will crush the market over the next 12 months. Get our report FREE by becoming a member now